Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $212B | +$1.72B | 201 | 3.84% | Increased |
|
| 2 |
BlackRock
New York
| $185B | +$1.22B | 205 | 3.89% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $94.6B | -$130M | 187 | 3.9% | Reduced |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $47.9B | +$1.4B | 218 | 3.77% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $44B | -$1.9B | 159 | 2.81% | Reduced |
|
| 6 |
JP Morgan Chase
New York
| $42B | +$5.84B | 194 | 3.06% | Increased |
|
| 7 |
Morgan Stanley
New York
| $40.1B | +$285M | 219 | 2.87% | Increased |
|
| 8 |
T. Rowe Price Associates
Baltimore,
Maryland
| $35.3B | +$885M | 125 | 4.35% | Increased |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $27.7B | -$2.29B | 69 | 5.33% | Reduced |
|
| 10 |
Norges Bank
Oslo,
Norway
| $26.6B | +$403M | 73 | 3.74% | Increased |
|
| 11 |
Bank of New York Mellon
New York
| $24.3B | -$147M | 145 | 4.82% | Reduced |
|
| 12 |
Capital Research Global Investors
Los Angeles,
California
| $24B | -$2.18B | 20 | 5.21% | Reduced |
|
| 13 |
Bank of America
Charlotte,
North Carolina
| $23.8B | +$3.23B | 225 | 1.92% | Increased |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $23.6B | -$282M | 190 | 3.5% | Reduced |
|
| 15 |
Invesco
Atlanta,
Georgia
| $22B | +$679M | 126 | 4.16% | Increased |
|
| 16 |
Massachusetts Financial Services
Boston,
Massachusetts
| $18.9B | +$320M | 51 | 6.28% | Increased |
|
| 17 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $18.3B | +$14.6M | 35 | 12.1% | Increased |
|
| 18 |
UBS AM
Chicago,
Illinois
| $18B | +$1.66B | 101 | 4.6% | Increased |
|
| 19 |
Franklin Resources
San Mateo,
California
| $15.2B | -$2.05B | 108 | 4.38% | Reduced |
|
| 20 |
Charles Schwab
San Francisco,
California
| $15.2B | +$319M | 142 | 2.85% | Increased |
|
| 21 |
Goldman Sachs
New York
| $14.3B | +$640M | 159 | 2.31% | Increased |
|
| 22 |
Dimensional Fund Advisors
Austin,
Texas
| $13.9B | +$511M | 128 | 3.46% | Increased |
|
| 23 |
Legal & General Group
London,
United Kingdom
| $13.8B | +$14.1M | 133 | 3.77% | Increased |
|
| 24 |
Nuveen
Charlotte,
North Carolina
| $13.6B | +$15.2M | 132 | 4.13% | Increased |
|
| 25 |
Capital International Investors
Los Angeles,
California
| $13.3B | -$904M | 9 | 2.61% | Reduced |
|